Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -32.51%
March 31, 2026 -77.84%
December 31, 2025 5.77%
September 30, 2025 -26.29%
June 30, 2025 -25.39%
March 31, 2025 -15.79%
December 31, 2024 -18.46%
September 30, 2024 -21.44%
June 30, 2024 -52.13%
March 31, 2024 -9.90%
December 31, 2023 -8.01%
September 30, 2023 -19.85%
June 30, 2023 -8.77%
March 31, 2023 -6.51%
December 31, 2022 -11.30%
September 30, 2022 -27.19%
June 30, 2022 -16.22%
March 31, 2022 -44.48%
December 31, 2021 -16.83%
September 30, 2021 84.10%
June 30, 2021 43.42%
March 31, 2021 39.60%
December 31, 2020 0.29%
September 30, 2020 -1.09%
June 30, 2020 -8.80%
Date Value
March 31, 2020 14.30%
December 31, 2019 6.01%
September 30, 2019 16.67%
June 30, 2019 -2.31%
March 31, 2019 12.57%
December 31, 2018 30.16%
September 30, 2018 35.75%
June 30, 2018 15.08%
March 31, 2018 4.23%
December 31, 2017 11.39%
September 30, 2017 3.52%
June 30, 2017 6.04%
March 31, 2017 13.94%
December 31, 2016 35.22%
September 30, 2016 19.18%
June 30, 2016 10.25%
March 31, 2016 -3.13%
December 31, 2015 14.81%
September 30, 2015 -8.68%
June 30, 2015 43.77%
March 31, 2015 -4.98%
December 31, 2014 3.33%
September 30, 2014 -18.93%
June 30, 2014 -1.88%
March 31, 2014 -22.75%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -18.02%
Codexis, Inc. -80.49%
Lonza Group AG --
Quanterix Corp. -148.7%
Sartorius Stedim Biotech SA 12.24%